Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Friday, October 11, 2024 · 750,907,115 Articles · 3+ Million Readers

Global Apheresis Market to Reach US$ 6.88 Billion by 2032, Growing at a 8.7% CAGR from 2024 to 2032 | Astute Analytica

CHICAGO, CA, UNITED STATES, October 10, 2024 /EINPresswire.com/ -- The global ๐’‚๐’‘๐’‰๐’†๐’“๐’†๐’”๐’Š๐’” ๐’Ž๐’‚๐’“๐’Œ๐’†๐’•, valued at ๐‘ผ๐‘บ$ 3,248.3 ๐’Ž๐’Š๐’๐’๐’Š๐’๐’ in 2023, is set to experience robust growth over the next decade, with projections indicating it will reach ๐‘ผ๐‘บ$ 6,882.1 ๐’Ž๐’Š๐’๐’๐’Š๐’๐’ by 2032. This surge, driven by increasing demand for therapeutic applications and technological advancements, marks a significant rise with a compound annual growth rate (๐‘ช๐‘จ๐‘ฎ๐‘น) ๐’๐’‡ 8.7% from 2024 to 2032.

๐†๐ž๐ญ ๐ข๐ง๐ฌ๐ข๐๐ž ๐’๐œ๐จ๐จ๐ฉ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ซ๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐Ÿ๐จ๐ซ ๐Ÿ๐ซ๐ž๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž: -https://www.astuteanalytica.com/request-sample/apheresis-market

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ

Apheresis is a medical technology where blood is drawn from a patient or donor and separated into its components. The required component is retained, and the rest is returned to the circulation. The procedure has found wide applications in treating several diseases, including autoimmune disorders, cancers, and hematologic conditions. With advancements in healthcare and technology, the global apheresis market is expected to witness substantial growth in the coming years.

๐Š๐ž๐ฒ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ

1. ๐‘ฎ๐’“๐’๐’˜๐’Š๐’๐’ˆ ๐‘ท๐’“๐’†๐’—๐’‚๐’๐’†๐’๐’„๐’† ๐’๐’‡ ๐‘ช๐’‰๐’“๐’๐’๐’Š๐’„ ๐’‚๐’๐’… ๐‘จ๐’–๐’•๐’๐’Š๐’Ž๐’Ž๐’–๐’๐’† ๐‘ซ๐’Š๐’”๐’†๐’‚๐’”๐’†๐’”
The rise in chronic conditions such as cancer, kidney diseases, and autoimmune disorders is a major driver of the apheresis market. Increasing cases of diseases like leukemia and lymphoma, where apheresis is used to collect stem cells, are propelling demand for these procedures.

2. ๐‘ฌ๐’™๐’‘๐’‚๐’๐’…๐’Š๐’๐’ˆ ๐‘ป๐’‰๐’†๐’“๐’‚๐’‘๐’†๐’–๐’•๐’Š๐’„ ๐‘จ๐’‘๐’‘๐’๐’Š๐’„๐’‚๐’•๐’Š๐’๐’๐’”
Apheresis has diversified beyond just treating blood-related conditions. Its use in treating neurological and autoimmune diseases, such as multiple sclerosis and myasthenia gravis, has broadened its application base. This is contributing to the marketโ€™s steady growth trajectory.

3. ๐‘ป๐’†๐’„๐’‰๐’๐’๐’๐’๐’ˆ๐’Š๐’„๐’‚๐’ ๐‘จ๐’…๐’—๐’‚๐’๐’„๐’†๐’Ž๐’†๐’๐’•๐’” ๐’Š๐’ ๐‘จ๐’‘๐’‰๐’†๐’“๐’†๐’”๐’Š๐’” ๐‘ซ๐’†๐’—๐’Š๐’„๐’†๐’”
Advances in medical technology have led to the development of more efficient, automated apheresis devices that reduce the time taken for the procedure and improve patient outcomes. These innovations are expected to further fuel market growth.

๐Œ๐š๐ซ๐ค๐ž๐ญ ๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง

1. ๐‘ฉ๐’š ๐‘ท๐’“๐’๐’…๐’–๐’„๐’•
Apheresis Devices
Disposable Apheresis Kits
Others
Among these, the disposable apheresis kits segment is expected to witness the fastest growth, owing to the rising demand for single-use components to avoid contamination and cross-infection risks.

2. ๐‘ฉ๐’š ๐‘ท๐’“๐’๐’„๐’†๐’…๐’–๐’“๐’†
Plasma Apheresis
Platelet Apheresis
Leukapheresis
Erythrocytapheresis
Others
Plasma apheresis dominates the market, driven by its extensive use in treating conditions like autoimmune disorders and plasma donation.

๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐ƒ๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: -https://www.astuteanalytica.com/request-sample/apheresis-market

3. ๐‘ฉ๐’š ๐‘จ๐’‘๐’‘๐’๐’Š๐’„๐’‚๐’•๐’Š๐’๐’
Renal Diseases
Hematologic Disorders
Neurological Disorders
Cardiovascular Diseases
Others
The renal disease segment is anticipated to witness substantial growth due to the increasing prevalence of chronic kidney diseases globally.

4. ๐‘ฉ๐’š ๐‘ฌ๐’๐’… ๐‘ผ๐’”๐’†๐’“
Hospitals
Blood Donation Centers
Ambulatory Surgical Centers
Others
Hospitals are the largest end-user segment, owing to their well-established infrastructure and the availability of skilled professionals to perform apheresis procedures.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ

๐‘ต๐’๐’“๐’•๐’‰ ๐‘จ๐’Ž๐’†๐’“๐’Š๐’„๐’‚
North America dominates the global apheresis market due to the high prevalence of chronic diseases, well-established healthcare infrastructure, and increasing government support for advanced medical treatments. The United States, in particular, leads in terms of market share.

๐‘ฌ๐’–๐’“๐’๐’‘๐’†
Europe is another key region, with significant growth observed in countries like Germany, the UK, and France. The increasing awareness of apheresis procedures and advancements in healthcare technology are contributing to the marketโ€™s growth.

๐‘จ๐’”๐’Š๐’‚-๐‘ท๐’‚๐’„๐’Š๐’‡๐’Š๐’„
The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, driven by the increasing healthcare expenditure, growing awareness about apheresis procedures, and the rising incidence of chronic diseases in countries like China and India.

๐‘ณ๐’‚๐’•๐’Š๐’ ๐‘จ๐’Ž๐’†๐’“๐’Š๐’„๐’‚ ๐’‚๐’๐’… ๐‘ด๐’Š๐’…๐’…๐’๐’† ๐‘ฌ๐’‚๐’”๐’• & ๐‘จ๐’‡๐’“๐’Š๐’„๐’‚
These regions are also projected to show steady growth, primarily due to the improving healthcare infrastructure and increased adoption of advanced medical procedures in emerging economies.

๐‚๐ก๐š๐ฅ๐ฅ๐ž๐ง๐ ๐ž๐ฌ ๐…๐š๐œ๐ž๐ ๐›๐ฒ ๐ญ๐ก๐ž ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Despite its promising growth, the global apheresis market faces several challenges. The high cost of apheresis procedures and devices, coupled with a lack of awareness in developing countries, may hinder market growth. Moreover, the need for skilled professionals to perform these procedures remains a barrier in certain regions, limiting the adoption of apheresis techniques.

๐…๐ฎ๐ญ๐ฎ๐ซ๐ž ๐Ž๐ฎ๐ญ๐ฅ๐จ๐จ๐ค ๐š๐ง๐ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ

The global apheresis market is set to expand significantly in the coming years. With increasing investment in healthcare infrastructure, particularly in emerging markets, and ongoing advancements in medical technology, the apheresis sector presents numerous growth opportunities.

Innovative treatments and devices, along with a rising focus on personalized medicine, are expected to open new avenues for the application of apheresis in the future. Strategic collaborations between key players and research institutions will likely accelerate product development and market penetration.

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐€๐ฉ๐ก๐ž๐ซ๐ž๐ฌ๐ข๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

Some of the prominent players in the global apheresis market include:

Terumo BCT, Inc.
Haemonetics Corporation
Asahi Kasei Medical Co., Ltd.
Fresenius Medical Care
Cerus Corporation
Macopharma
Medica SPA
Kaneka Corporation
These companies are focusing on product innovation, mergers, and partnerships to expand their global footprint and maintain a competitive edge.

๐‚๐จ๐ง๐œ๐ฅ๐ฎ๐ฌ๐ข๐จ๐ง

The global apheresis market is poised for substantial growth, driven by technological advancements, rising demand for therapeutic applications, and the increasing prevalence of chronic diseases. As the market is projected to reach US$ 6,882.1 million by 2032, healthcare providers and medical device companies are presented with significant opportunities to innovate and expand their offerings to meet the growing demand.

๐’๐ž๐œ๐ฎ๐ซ๐ž ๐˜๐จ๐ฎ๐ซ ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐…๐ฎ๐ฅ๐ฅ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ: -https://www.astuteanalytica.com/request-sample/apheresis-market

๐€๐›๐จ๐ฎ๐ญ ๐€๐ฌ๐ญ๐ฎ๐ญ๐ž ๐€๐ง๐š๐ฅ๐ฒ๐ญ๐ข๐œ๐š:

Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth, and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the globe.

Mirza Aamir Beg
Astute Analytica
+91 99108 20439
email us here

Powered by EIN Presswire

Distribution channels: Healthcare & Pharmaceuticals Industry

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Submit your press release